Ceo of Cannabis Company Says Legal Weed Could Result in Fewer Opioid Prescriptions in the Us

Legalizing marijuana at the federal level in the U.S. could result in fewer prescriptions of addictive substances such as opioids, Canopy Growth founder and CEO Bruce Linton told CNBC on Thursday.

Linton, whose Canada based-company has partnered with names such as cannabis icon Snoop Dogg and alcohol leader Constellation Brands, said that in other regions of the world, marijuana has even influenced the sale of other products such as alcohol and sleep aids.

“Cannabis is a huge disruptor to the opioid guys,” Linton told “Mad Money” host Jim Cramer in an exclusive interview. He said his company is looking at other possible uses for marijuana in the health-care space.

Opioids, including heroin and fentanyl, were involved in more than 42,000 overdose deaths in 2016, according to the Centers for Disease Control and Prevention.

– Read the entire article at CNBC News.